Cargando…
Nucleocapsid Protein: A Desirable Target for Future Therapies Against HIV-1
The currently available anti-HIV-1 therapeutics is highly beneficial to infected patients. However, clinical failures occur as a result of the ability of HIV-1 to rapidly mutate. One approach to overcome drug resistance is to target HIV-1 proteins that are highly conserved among phylogenetically dis...
Autores principales: | Mori, Mattia, Kovalenko, Lesia, Lyonnais, Sébastien, Antaki, Danny, Torbett, Bruce E., Botta, Maurizio, Mirambeau, Gilles, Mély, Yves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122173/ https://www.ncbi.nlm.nih.gov/pubmed/25749978 http://dx.doi.org/10.1007/82_2015_433 |
Ejemplares similares
-
HIV-1 Protease and Reverse Transcriptase Control the Architecture of Their Nucleocapsid Partner
por: Mirambeau, Gilles, et al.
Publicado: (2007) -
Inhibitory Effect of Lithospermic Acid on the HIV-1 Nucleocapsid Protein
por: Mori, Mattia, et al.
Publicado: (2020) -
RNA remarkably promotes HIV-1 protease fast turnover for NCp15 processing in mild acidic conditions leading to condensation of HIV-1 nucleocapsid
por: Lyonnais, Sebastien, et al.
Publicado: (2013) -
The HIV-1 Nucleocapsid Regulates Its Own Condensation by Phase-Separated Activity-Enhancing Sequestration of the Viral Protease during Maturation
por: Lyonnais, Sébastien, et al.
Publicado: (2021) -
FRET-based assay to screen inhibitors of HIV-1 reverse transcriptase and nucleocapsid protein
por: Sharma, Kamal K., et al.
Publicado: (2016)